Robert Ryan

Robert Ryan is a Professor and Interim Chair of the Natural Resources and Environmental Science Department at the University of Nevada, Reno, with research centered on cardiovascular disease mechanisms and therapeutic interventions. His work bridges molecular biochemistry with clinical applications, focusing on lipid metabolism aberrations as key risk factors for heart disease. Affiliated with the Health Sciences Building (HMS), his laboratory investigates exchangeable apolipoproteins and their role in plasma lipid regulation.

Education

• B.S. from University of Nevada, 1977
• Ph.D. from University of Nevada, 1982

Research Focus: His primary interests include cardiovascular disease pathogenesis, lipid metabolism dysregulation, apolipoprotein functionality, dyslipidemias, and hypercholesterolemia. He explores how molecular properties of exchangeable apolipoproteins influence plasma lipid levels and contribute to conditions like childhood and adult metabolic disorders. Recent work emphasizes nanodisc-based drug delivery systems for targeting mitochondrial dysfunction and metabolic biomarkers.

Publication Trends: Analysis of his 15 most recent articles (2022-2025) reveals three dominant themes: (1) Nanodisc technology for therapeutic delivery (cardiolipin, lutein, and coenzyme Q formulations), (2) Molecular mechanisms of 3-methylglutaconyl CoA in protein acylation and mitochondrial disorders, and (3) Clinical applications in cardiovascular and metabolic diseases. His work consistently connects basic biochemical discoveries to translational solutions for dyslipidemias and cardiomyopathy.